New Products In Brief
This article was originally published in The Tan Sheet
Executive Summary
Unisom extension targets nighttime pain: Sanofi-Aventis introduces the first dual-ingredient stock-keeping unit in the Unisom sleep-aid line, pairing diphenhydramine 50 mg with acetaminophen 325 mg in Unisom PM Pain SleepCaps. The product sells at $8.99 for 30 caplets. Unisom PM Pain's indication says it helps "relieve occasional sleeplessness when accompanied by a headache or other minor aches and pains," according to its website. Johnson & Johnson/McNeil is seeking FDA approval of a more explicit sleep-aid/pain relief indication for its similar Tylenol PM (diphenhydramine 25 mg/acetaminophen 500 mg) (1"The Tan Sheet" Aug. 23, 2010)
You may also be interested in...
P&G’s ZzzQuil Emerges As Sleep Aid Giant In Fragmented Category
The combination of appealing marketing, single-ingredient formulation and Vicks brand equity helped Procter & Gamble’s ZzzQuil rise to the top of the sleep aid segment. The firm recruited actress Katherine Heigl as ZzzQuil ambassador to help amplify the brand’s marketing strategy in its second year.
P&G’s ZzzQuil Emerges As Sleep Aid Giant In Fragmented Category
The combination of appealing marketing, single-ingredient formulation and Vicks brand equity helped Procter & Gamble’s ZzzQuil rise to the top of the sleep aid segment. The firm recruited actress Katherine Heigl as ZzzQuil ambassador to help amplify the brand’s marketing strategy in its second year.
In Brief
Abbott's Ensure claims convince NAD